In the BioHarmony Drug Report Database

"Preview" Icon

Mercaptamine

Cystagon, Procysbi (cysteamine) is a small molecule pharmaceutical. Cysteamine was first approved as Cystagon on 1994-08-15. It is used to treat cystinosis in the USA. Cystagon’s patents are valid until 2036-08-16 (FDA).

 

Trade Name

 

Cystagon, Procysbi
 

Common Name

 

cysteamine
 

ChEMBL ID

 

CHEMBL602
 

Indication

 

cystinosis
 

Drug Class

 

Image (chem structure or protein)

Mercaptamine structure rendering